Kim D Blickenstaff - Net Worth and Insider Trading

Kim D Blickenstaff Net Worth

The estimated net worth of Kim D Blickenstaff is at least $7 Million dollars as of 2024-04-19. Kim D Blickenstaff is the Director of Tandem Diabetes Care Inc and owns about 215,847 shares of Tandem Diabetes Care Inc (TNDM) stock worth over $7 Million. Kim D Blickenstaff is the Director of Medivation Inc and owns about 7,114 shares of Medivation Inc (MDVN) stock worth over $579,364. Kim D Blickenstaff is also the Director of DexCom Inc and owns about 0 shares of DexCom Inc (DXCM) stock worth over $0. Details can be seen in Kim D Blickenstaff's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Kim D Blickenstaff has not made any transactions after 2022-05-17 and currently still holds the listed stock(s).

Transaction Summary of Kim D Blickenstaff

To

Kim D Blickenstaff Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Kim D Blickenstaff owns 5 companies in total, including Tandem Diabetes Care Inc () , Medivation Inc () , and DexCom Inc () among others .

Click here to see the complete history of Kim D Blickenstaff’s form 4 insider trades.

Insider Ownership Summary of Kim D Blickenstaff

Ticker Comapny Transaction Date Type of Owner
Tandem Diabetes Care Inc 2022-05-17 director & PRESIDENT AND CEO
Medivation Inc 2016-09-28 director
DexCom Inc 2006-03-13 director
Nuvation Bio Inc 2021-02-10 director
OPY Acquisition Corp I 2021-10-26 director

Kim D Blickenstaff Latest Holdings Summary

Kim D Blickenstaff currently owns a total of 3 stocks. Among these stocks, Kim D Blickenstaff owns 215,847 shares of Tandem Diabetes Care Inc (TNDM) as of May 17, 2022, with a value of $7 Million and a weighting of 92.01%. Kim D Blickenstaff owns 7,114 shares of Medivation Inc (MDVN) as of November 21, 2013, with a value of $579,364 and a weighting of 7.99%. Kim D Blickenstaff also owns 0 shares of DexCom Inc (DXCM) as of March 13, 2006, with a value of $0 and a weighting of 0%.

Latest Holdings of Kim D Blickenstaff

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TNDM Tandem Diabetes Care Inc 2022-05-17 215,847 30.93 6,676,148
MDVN Medivation Inc 2013-11-21 7,114 81.44 579,364
DXCM DexCom Inc 2006-03-13 0 134.30 0

Holding Weightings of Kim D Blickenstaff


Kim D Blickenstaff Form 4 Trading Tracker

According to the SEC Form 4 filings, Kim D Blickenstaff has made a total of 22 transactions in Tandem Diabetes Care Inc (TNDM) over the past 5 years, including 0 buys and 22 sells. The most-recent trade in Tandem Diabetes Care Inc is the sale of 10,762 shares on May 17, 2022, which brought Kim D Blickenstaff around $999,897.

According to the SEC Form 4 filings, Kim D Blickenstaff has made a total of 0 transactions in Medivation Inc (MDVN) over the past 5 years. The most-recent trade in Medivation Inc is the sale of 60,000 shares on November 21, 2013, which brought Kim D Blickenstaff around $2 Million.

According to the SEC Form 4 filings, Kim D Blickenstaff has made a total of 0 transactions in DexCom Inc (DXCM) over the past 5 years. The most-recent trade in DexCom Inc is the sale of 160,000 shares on March 13, 2006, which brought Kim D Blickenstaff around $185,700.

Insider Trading History of Kim D Blickenstaff

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Kim D Blickenstaff Trading Performance

GuruFocus tracks the stock performance after each of Kim D Blickenstaff's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kim D Blickenstaff is 53.53%. GuruFocus also compares Kim D Blickenstaff's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kim D Blickenstaff within 3 months outperforms 1 times out of 4 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Kim D Blickenstaff's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Kim D Blickenstaff

Average Return

667.94%

Average return per transaction

Outperforming Transactions

50%

2 out of 4 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 5.11 53.53 316.72 667.94 268.24 154.15
Relative Return to S&P 500(%) 3.14 48.53 310.14 659.84 258.44 148.57

Kim D Blickenstaff Ownership Network

Ownership Network List of Kim D Blickenstaff

No Data

Ownership Network Relation of Kim D Blickenstaff


Kim D Blickenstaff Owned Company Details

What does Tandem Diabetes Care Inc do?

Who are the key executives at Tandem Diabetes Care Inc?

Kim D Blickenstaff is the director & PRESIDENT AND CEO of Tandem Diabetes Care Inc. Other key executives at Tandem Diabetes Care Inc include SVP & General Counsel Shannon Marie Hansen , Senior Vice President and CFO Leigh Vosseller , and GENERAL COUNSEL David B Berger .

Tandem Diabetes Care Inc () Insider Trades Summary

Over the past 18 months, Kim D Blickenstaff made no insider transaction in Tandem Diabetes Care Inc (). Other recent insider transactions involving Tandem Diabetes Care Inc () include a net sale of 35,000 shares made by David B Berger , a net purchase of 15,000 shares made by Dick Allen , and a net purchase of 6,200 shares made by Leigh Vosseller .

In summary, during the past 3 months, insiders sold 0 shares of Tandem Diabetes Care Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 35,000 shares of Tandem Diabetes Care Inc () were sold and 27,135 shares were bought by its insiders, resulting in a net sale of 7,865 shares.

Tandem Diabetes Care Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Tandem Diabetes Care Inc Insider Transactions

No Available Data

Kim D Blickenstaff Mailing Address

Above is the net worth, insider trading, and ownership report for Kim D Blickenstaff. You might contact Kim D Blickenstaff via mailing address: C/o Medivation, Inc., 201 Spear Street, 3rd Floor, San Francisco Ca 94105.

Discussions on Kim D Blickenstaff

No discussions yet.